Metavention
Metavention is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 1 tracked investor.
About Metavention
Based in the United States, Metavention is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Metavention develops the iRF Denervation System, a minimally invasive, one-time renal denervation device that uses radiofrequency energy to disrupt overactive sympathetic nerves associated with high blood pressure and metabolic diseases. The company is conducting clinical studies and its device is currently for investigational use under U.S. federal law.
Explore Metavention's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.